Profound Medical Corp.PROFNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank73
5Y CAGR+38.1%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+38.1%/yr
Long-term compound
Percentile
P73
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 27.53% |
| 2024 | 12.34% |
| 2023 | -2.13% |
| 2022 | -3.84% |
| 2021 | 54.13% |
| 2020 | 5.48% |
| 2019 | 24.68% |
| 2018 | -1.67% |
| 2017 | 3.14% |
| 2016 | 100.76% |